Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway

Oral Oncology

Volumn 49, Issue 12, 2013, Pages 1113-1120

  Xie, Yuxin ^a   Li, Yan ^a   Peng, Xinchen ^a   Henderson, Fraser ^b   Deng, Ling ^a   Chen, Nianyong ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Alternative NF B; ERK; Ikappa B kinase alpha; Nasopharyngeal carcinoma; NF B; Non canonical NF B; Tumor suppressor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; EPSTEIN BARR VIRUS ANTIGEN 1; GELATINASE B; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SIZE; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALTERNATIVE NF-ΚB; ERK; IKAPPA B KINASE ALPHA; NASOPHARYNGEAL CARCINOMA; NF-ΚB; NON-CANONICAL NF-ΚB; TUMOR SUPPRESSOR;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; I-KAPPA B KINASE; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; MICE; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; PHOSPHORYLATION;

EID: 84888645312     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.08.008     Document Type: Article

References (37)

1. Li X, Liu X, Li CY, Ding Y, Chau D, Li G, et al. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1. Int J Oncol 2006;29:595-603.
2. Zhao Y, Wang Y, Zeng S, Hu X. LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis. J Clin Pathol 2012;65:41-5.
3. Chan AT. Nasopharyngeal carcinoma. Ann Oncol 2010;21(Suppl. 7):308-12.
4. Busson P, Ooka T, Corbex M. Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. Med Sci 2004;20:453-7.
5. Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: rosetta stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol 2012;22:107-16.
6. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokineresponsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54.
7. Karin M. The IkappaB kinase - a bridge between inflammation and cancer. Cell Res 2008;18:334-42.
8. Ding L, Li LL, Yang J, Tao YG, Ye M, Shi Y, et al. Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells. Int J Biochem Cell Biol 2005;37:1881-9.
9. Shi W, Bastianutto C, Li A, Perez-Ordonez B, Ng R, Chow KY, et al. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 2006;119:2467-75.
10. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003;22:5108-21.
11. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKαlpha controls formation of the epidermis independently of NF-kappaB. Nature 2001;410:710-4.
12. Liu B, Xia X, Zhu F, Park E, Carbajal S, Kiguchi K, et al. IKKαlpha is required to maintain skin homeostasis and prevent skin cancer. Cancer cell 2008;14: 212-25.
13. Liu B, Park E, Zhu F, Bustos T, Liu J, Shen J, et al. A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci USA 2006;103:17202-7.
14. Maeda G, Chiba T, Kawashiri S, Satoh T, Imai K. Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression. Clin Cancer Res 2007;13:5041-7.
15. Sil AK, Maeda S, Sano Y, Roop DR, Karin M. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 2004;428:660-4.
16. Park E, Liu B, Xia X, Zhu F, Jami WB, Hu Y. Role of IKKαlpha in skin squamous cell carcinomas. Future Oncol 2011;7:123-34.
17. Lam LT, Davis RE, Ngo VN, Lenz G, Wright G, Xu W, et al. Compensatory IKKαlpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen. Proc Natl Acad of Sci USA 2008;105:20798-803.
18. Cao JY, Mansouri S, Frappier L. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J Virol 2012;86:382-94.
19. Van Waes C. Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 2007;13:1076-82.
20. Sun SC. Non-canonical NF-kappaB signaling pathway. Cell Res 2011;21:71-85.
21. Wu ZZ, Chow KP, Kuo TC, Chang YS, Chao CC. Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-kappaB p50 homodimer formation and downregulating NAPA expression. Biochem Pharmacol 2011;82:1860-72.
22. Lan YY, Hsiao JR, Chang KC, Chang JS, Chen CW, Lai HC, et al. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9. J Virol 2012;86:6656-67.
23. Valentine R, Dawson CW, Hu C, Shah KM, Owen TJ, Date KL, et al. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol Cancer 2010;9:1.
24. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 2007;38:120-33.
25. Sun W, Guo MM, Han P, Lin JZ, Liang FY, Tan GM, et al. Id-1 and the p65 subunit of NF-kappaB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. Carcinogenesis 2012;33:810-7.
26. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006;66:8319-26.
27. Demers M, Couillard J, Belanger S, St-Pierre Y. New roles for matrix metalloproteinases in metastasis. Crit Rev Immunol 2005;25:493-523.
28. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007;26:3291-310.
29. Cuevas BD, Winter-Vann AM, Johnson NL, Johnson GL. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer. Oncogene 2006;25:4998-5010.
30. Neuzillet C, Hammel P, Tijeras-Raballand A, Couvelard A, Raymond E. Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. Cancer Metastasis Rev 2013;32:147-62.
31. Friday BB, Adjei AA. Advances in targeting the Ras/Raf/MEK/Erk mitogenactivated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 2008;14:342-6.
32. Park E, Zhu F, Liu B, Xia X, Shen J, Bustos T, et al. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res 2007;67:9158-68.
33. Bernhard EJ, Gruber SB, Muschel RJ. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 1994; 91:4293-7.
34. Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 2004;10:7621-8.
35. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357-64.
36. Frappier L. Role of EBNA1 in NPC tumourigenesis. Semin Cancer Biol 2012;22: 154-61.
37. Sivachandran N, Thawe NN, Frappier L. Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines. J Virol 2011;85:10425-30.